Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

allergan

Allergan snaps up Vitae Pharma for $639 million

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition

Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …
News
c_nito_-_fotolia

UK Biopharma and life after Brexit

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …
Feature
hero-plus

Mylan CEO to appear before US congress over EpiPen scandal

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Hilary Clinton, Mylan, epipen

Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …
News
gsk-house-location-building

GSK’s shingles vaccine tops MSD rival in Ph III testing

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GlaxoSmithKline’s shingles vaccine Shingrix has topped rival MSD treatment Zostavax as it is shown to remain effective in elderly patients …
News
eisa0001

EU approval for Eisai kidney cancer treatment

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, Eisai, Kisplyx, Lenvima, everolimus

The European Commission has approved the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma (RCC) following …
News
sanofi_hq__boetie_hall

Sanofi reveals promising data for FDA-delayed diabetes drug

September 14, 2016 Research and Development, Sales and Marketing FDA, Lantus, Sanofi, iglarlixi

Sanofi has announced new Phase III data for its IGlarLixi combination drug for the treatment of diabetes, showing it could …
News

Bayer raises bid yet again to finalise Monsanto deal

September 14, 2016 Manufacturing and Production, Research and Development, Sales and Marketing

Bayer has taken yet another step in its dedicated efforts to acquire Monsanto as it raises its offer to $129 …
News
images

Roche’s Ocrevus more effective than Merck’s Rebif, company claims

September 14, 2016 Research and Development Merck, Ocrevus, Rebif, Roche, multiple sclerosis

Roche has announced new results from the Phase III studies of investigational medicine Ocrevus (ocrelizumab) studying relapsing multiple sclerosis (RMS) …
News
entrance_takeda_i020_v1

Takeda reportedly sets $15bn on US acquisitions

September 14, 2016 Manufacturing and Production, Research and Development Takeda, acquisitions

Takeda Pharmaceuticals is reportedly willing to spend as much as $15 billion on acquisitions in the US in efforts to …
News
shutterstock_168864905

Novartis joins $17m funding of chronic inflammatory disease startup

September 14, 2016 Research and Development Fountain Healthcare, Novartis, start up financing

Novartis was one of the co-leaders in the $17million series A financing of Irish startup in the development of chronic …
News
rick_farris

ClinTec appoints Rick Farris as executive vice president of North American Operations

September 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ClinTec, appointment

Clinical research organisation ClinTec has announced the expansion of its US management team with the selection of Rick Farris as …
Appointment
eisa0008

Eisai reveals new long-term seizure control data at ECE 2016

September 13, 2016 Manufacturing and Production, Research and Development Eisai, epilepsy

Eisai has revealed new data on long-term seizure control in different seizure types at the 12th European Congress on Epileptology …
News
web_scientist-filling-out-form---credit-national-institutes-of-health

Proteomics market to grow to $24.8 billion by 2024

September 13, 2016 Manufacturing and Production, Research and Development Grand View Research, proteomics

The global proteomics market is predicted to grow to exceed $24.8 billion by 2024, according to a new report by …
News
takeda_world

Takeda forms “first of its kind” developmental partnership with CRO

September 13, 2016 Manufacturing and Production, Research and Development PRA Health Services, Takeda, partnership

Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …
News

New Sanofi/Alphabet partnership names CEO

September 12, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alphabet, Sanofi, Verily, appointment, google

As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026